A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

ULAN BATOR, Jan. 24 (Xinhua) -- Mongolia has so far vaccinated at least 20,682 children aged 11 against human papillomavirus (HPV) as part of a nationwide campaign, according to a report released on ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial published ...

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

In this week’s Healthier Together, KIRO 7′s Ranji Sinha sat down with Dr. Nicole Saint Clair, Executive Medical Director of Regence BlueShield, to discuss the issues around cervical cancer. Dr. Saint ...

Robert F. Kennedy Jr. is openly vowing to make money off vaccine lawsuits if confirmed as the next HHS secretary.

Basu Chatterjee’s legal drama Ek Ruka Hua Faisla (A Paused Decision), itself an adaptation of a Hollywood film, has achieved ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Key Takeaways Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck ...